Animal models for nicotine dependence are critical for investigating molecular mechanisms associated with this addiction. The mouse is a tractable model that allows for dissection of these mechanisms at a level not afforded by human studies. In particular, genetically-altered mice can be used to analyze a variety of complex functions including those associated with addiction. A variety of drugs of abuse, such as morphine, cocaine and more recently nicotine, have been shown to activate the transcription factor CREB (CAMP response element binding protein) in the brain. We will utilize mice homozygous for a targeted mutation in CREB (CREBaD mutant mice) to test the hypothesis that CREB is a central signaling molecule required for the addictive properties of nicotine. We will test this central hypothesis in three specific aims. First, we will investigate if activation of the transcription factor CREB is critical for the manifestation of rewarding effects of nicotine using a conditioned place preference paradigm (CPP) for nicotine in wild type and CREBaD mutant mice. Next, we will determine if CREB is critical for the manifestation of aversive effects of nicotine withdrawal and/or the underlying mechanism responsible for the maintenance of nicotine reward. We will treat wild type and CREBaD mutant mice with nicotine and evaluate both physical (somatic signs) and psychological (conditioned place aversion) signs of withdrawal. Furthermore, the effects of a withdrawal period on subsequent rewarding properties of nicotine will also be evaluated. Lastly, we will establish if the rewarding properties of nicotine are mediated through the endogenous opioid system, and if this occurs in a CREB dependent manner. We will utilize the opioid receptor antagonist naloxone, as well as mv-opioid receptor knock-out mice to evaluate changes in CREB activation and behavioral responses in conditioned place preference following acute and chronic nicotine administration. Together, these studies will provide insights into the molecular mechanisms underlying nicotine reward as well as interactions between nicotine and the endogenous opioid system. The complete understanding of these mechanisms would open new perspectives for the successful treatment of nicotine addiction.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA084718-09
Application #
7289192
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2006-09-30
Budget End
2007-09-29
Support Year
9
Fiscal Year
2006
Total Cost
$127,827
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hsu, Ping-Ching; Lan, Renny S; Brasky, Theodore M et al. (2017) Metabolomic profiles of current cigarette smokers. Mol Carcinog 56:594-606
Hsu, Ping-Ching; Lan, Renny S; Brasky, Theodore M et al. (2017) Menthol Smokers: Metabolomic Profiling and Smoking Behavior. Cancer Epidemiol Biomarkers Prev 26:51-60
Weng, Daniel Y; Chen, Jinguo; Taslim, Cenny et al. (2016) Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers. Mol Carcinog 55:1424-37
Song, Min-Ae; Marian, Catalin; Brasky, Theodore M et al. (2016) Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products. Toxicol Lett 245:68-77
Schnoll, Robert A; Goelz, Patricia M; Veluz-Wilkins, Anna et al. (2015) Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Intern Med 175:504-11
David, Sean P; Strong, David R; Leventhal, Adam M et al. (2013) Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction 108:2202-11
Bough, K J; Lerman, C; Rose, J E et al. (2013) Biomarkers for smoking cessation. Clin Pharmacol Ther 93:526-38
Perkins, Kenneth A; Parzynski, Craig; Mercincavage, Melissa et al. (2012) Is self-efficacy for smoking abstinence a cause of, or a reflection on, smoking behavior change? Exp Clin Psychopharmacol 20:56-62
Conklin, Cynthia A; Parzynski, Craig S; Salkeld, Ronald P et al. (2012) Cue reactivity as a predictor of successful abstinence initiation among adult smokers. Exp Clin Psychopharmacol 20:473-8
Featherstone, Robert E; Phillips, Jennifer M; Thieu, Tony et al. (2012) Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials. PLoS One 7:e39775

Showing the most recent 10 out of 148 publications